Going Concern (worsened) — Baseline stated existing cash and October 2024 financing insufficient; current states three 2025 equity raises plus revolving note still insufficient for twelve months.
Material Weakness (improved) — Material weaknesses persist but count reduced from five to three; two prior weaknesses remediated.

NASDAQ: SHPH Shuttle Pharmaceuticals Holdings, Inc. 10-K

SHPH pivots to AI drug-discovery platform, winds down clinical trials, burns $11.7M

Filed March 31, 2026 · Period ending December 31, 2025 · Compared to 10-K Feb 26, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SHPH commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 4, 2026 12:13 AM